Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Idiopathic thrombocytopenic purpura patient report clinical outcome evaluation system

An evaluation system and platelet technology, applied in medical reports, electronic clinical trials, instruments, etc., can solve the problems of wasting diagnostic resources and time, overlapping symptom classification, affecting disease recognition and treatment, etc.

Pending Publication Date: 2021-12-03
内蒙古民族大学附属医院
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This traditional way of thinking will cause several problems in clinical treatment: (1) Symptoms that appear in a certain system do not necessarily indicate the problem of that system, so when no problem can be found in the corresponding system by following the symptoms, Diagnosis and treatment activities cannot continue, and referring patients to other disciplines means restarting diagnosis and treatment activities, which wastes diagnostic resources and time; (2) Some symptoms have overlapping classifications, so it is difficult to locate them in a certain category. A system, such as vomiting can be classified as a symptom of the digestive system, can also be classified as a symptom of the nervous system; (3) a cause must lead to a result, this unified thinking mode can make clinical thinking absolute, fixed and "standardized", But in fact, one cause can lead to more than one result. On the contrary, a result can be caused by multiple reasons. The lack of diversified thinking modes and the habit of considering a problem from multiple angles will inevitably lead to the rigidity of clinical and scientific thinking, thus affecting to disease awareness and treatment
There are differences in the description of disease symptoms in clinical practice, often ignoring the evaluation of patients' self-feeling

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Idiopathic thrombocytopenic purpura patient report clinical outcome evaluation system

Examples

Experimental program
Comparison scheme
Effect test

no. 2 example

[0262] Second embodiment: preliminary evaluation of PRO scale.

[0263] 1. Research purpose

[0264] Preliminary evaluation of the reliability and validity of the patient-reported outcome scale for idiopathic thrombocytopenic purpura.

[0265] 2. Research content

[0266] The evaluation of the scale generally includes reliability analysis and validity analysis. Based on the data from the above-mentioned on-site investigations, we assessed the reliability and validity of the initially formed scale. The pre-investigation was carried out in 4 sub-centers to evaluate the reliability and validity of the scale. Through the method of scale research, gradually develop and try to establish a patient-reported outcome scale for idiopathic thrombocytopenic purpura.

[0267] 3. Overall design.

[0268] Test basis and principles;

[0269] ●Project mission statement supported by the Ministry of Science and Technology

[0270] ●Medical Ethics

[0271] ●Medical statistics experts invol...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of methods for calculating health indexes and (or) evaluating personal health risks in medical application, in particular to an idiopathic thrombocytopenic purpura patient report clinical outcome evaluation system. The idiopathic thrombocytopenic purpura is analyzed based on the Mongolian medicine overall theory through Delphi methods such as expert consultation and patient interview; the method is divided according to three dimensions of body symptoms, psychology, society and the like of the patients, and an outcome scale of idiopathic thrombocytopenic purpura patients for self-feeling measurement of the developed patients is reported to the patients with idiopathic thrombocytopenic purpura. The evaluation system comprises expert questionnaires screened by entries of the outcome evaluation scale and patient questionnaires screened by entries of the outcome evaluation scale, wherein the expert questionnaire screened by the entries of the outcome evaluation scale comprises but is not limited to a plurality of questions. The idiopathic thrombocytopenic purpura patient report outcome scale can be used for measuring the self feeling of the idiopathic thrombocytopenic purpura patient and evaluating the effect of Mongolian medicine characteristic therapy.

Description

technical field [0001] The invention relates to the technical field of methods for calculating health indexes and (or) personal health risk assessments in medical applications, in particular to a clinical outcome assessment system reported by patients with idiopathic thrombocytopenic purpura. Background technique [0002] ITP overview [0003] Idiopathic thrombocytopenic purpura (ITP), also known as idiopathic thrombocytopenic purpura, is an acquired bleeding disorder of unknown cause characterized by thrombocytopenia, normal or increased bone marrow megakaryocytes, and the absence of any cause . The incidence of ITP in women of childbearing age is higher than that in men, and there is no difference in the ratio of men and women in other age groups. ITP can be classified according to duration into newly diagnosed, persistent and chronic. Typical adult cases generally have insidious onset, no obvious history of viral infection or other diseases before the disease, and the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G16H15/00G16H50/30G16H10/20
CPCG16H15/00G16H50/30G16H10/20
Inventor 布仁巴图额尔敦都楞王双连龚翠琴乌日图那顺娜日苏任小满特木勒巴根越长成乌日嘎
Owner 内蒙古民族大学附属医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products